Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Operating activities:
Net income	$ 141,708	$ 144,533
Add non-cash items included in net income:
Depreciation and amortization	117,402	121,174
Share-based compensation	15,425	11,402
Other non-cash items	5,685	5,213
Changes in assets and liabilities:
Accounts receivable	5,006	94,400
Inventories	(34,831)	(26,442)
Accounts payable	(5,326)	(40,976)
Other current assets and liabilities	9,605	(7,183)
Other assets and liabilities	(97)	(10,608)
Cash provided from operating activities	254,577	291,513
Investing activities:
Capital expenditures	(148,041)	(95,055)
Acquisitions	(55,299)	(24,000)
Proceeds from sales of property, plant and equipment	3,020	2,202
Proceeds from sales or maturities of marketable securities	8,399	6,553
Purchases of marketable securities	(5,081)	(4,787)
Insurance proceeds and other investing activities	9,957
Cash used for investing activities	(187,045)	(115,087)
Financing activities:
Proceeds from revolving credit facility	90,000	75,000
Payments on revolving credit facility	(10,000)	(220,000)
Proceeds from short-term loans and debt	178,089
Payments on short-term loans and debt	(158,620)	(27,389)
Proceeds from issuance of long-term debt		149,713
Cash dividends paid	(116,706)	(70,186)
Exercise of stock options	4,804	2,630
Other financing activities	(2,115)	(2,087)
Cash used for financing activities	(14,548)	(92,319)
Effect of exchange rate changes on cash	14,646	(9,370)
Net increase in cash and cash equivalents	67,630	74,737
Cash and cash equivalents, beginning of period	637,417	532,599
Cash and cash equivalents, end of period	$ 705,047	$ 607,336